Chicago, IL, United States of America

Alexander D Huters

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 20.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alexander D Huters: Innovator in Parkinson's Disease Treatment

Introduction

Alexander D Huters is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. With a total of 2 patents, Huters has focused on developing innovative solutions to improve patient outcomes.

Latest Patents

Huters' latest patents include advancements in carbidopa and L-dopa prodrugs and methods of use. The present disclosure relates to (a) carbidopa prodrugs, (b) pharmaceutical combinations and compositions comprising a carbidopa prodrug and/or an L-dopa prodrug, and (c) methods of treating Parkinson's disease and associated conditions. These methods involve administering a carbidopa prodrug and an L-dopa prodrug to a subject with Parkinson's disease, showcasing his commitment to addressing this challenging condition.

Career Highlights

Huters is currently associated with AbbVie Inc., a leading biopharmaceutical company. His work at AbbVie has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Benoit Cardinal-David and Vincent S Chan. Their collective expertise enhances the innovative environment at AbbVie, fostering advancements in pharmaceutical research.

Conclusion

Alexander D Huters is a dedicated inventor whose work in developing carbidopa and L-dopa prodrugs is making a significant impact on the treatment of Parkinson's disease. His contributions to the field exemplify the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…